The present study demonstrated that low expression of semaphorin-3A and high expression of MMP-14 in NSCLC may promote tumor progression, possibly due to negative synergy, and the combined detection of semaphorin-3A and MMP-14 postoperatively was valuable in the judgment of prognosis. This evidence concerns the gene SEMA3A and neoplasm.